Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYCLONE: Carfilzomib, Cyclophosphamide, Thalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma
NCT01057225Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2010
- Primary completion
- Mar 2014
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of carfilzomib in multiple myeloma (MM), sponsored by Mayo Clinic. Started Mar 2010; status: completed.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01057225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01057225.